Clinical Trials Directory

Trials / Completed

CompletedNCT00592345

High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test the effectiveness of high dose radiation administered by both proton and photon therapy. Radiation is an effective treatment for many types of tumors and it is thought that radiation alone, when given in much higher doses over a shorter period of time, may be more effective in controlling recurrence of sarcoma.

Detailed description

* In this study three types of radiation will be used: standard radiation (called photon); alternative form of radiation called proton beam therapy; and a localized radiation applicator plaque that can be applied to the surface of the dura (the fibrous outer envelope that surrounds the spinal cord and fluid surrounding the spinal cord) at time of surgical removal of the tumor. * Radiation treatments (photon and proton) and possibly surgical removal of portions of the tumor with intraoperative radiation delivery to the surface dura with intraoperative radiation delivery will be performed over a period of 12 weeks. As part of the treatment planning process, participants will need two treatment planning CT scans and 2-3 treatment planning sessions. * Participants will receive, in total, 39-43 photon/proton treatments.

Conditions

Interventions

TypeNameDescription
RADIATIONProton Beam RadiationAdministered over a period of 12 weeks.
RADIATIONPhoton Beam RadiationAdministered over a period of 12 weeks.
RADIATIONInteroperative radiationRadioactive plaque applied at the time of surgical removal of the tumor.

Timeline

Start date
1999-05-01
Primary completion
2005-03-01
Completion
2016-03-01
First posted
2008-01-14
Last updated
2017-02-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00592345. Inclusion in this directory is not an endorsement.